Management of pelvic organ prolapse during pregnancy: Case report

During pregnancy, pelvic organ prolapse is uncommon and is associated with adverse outcomes such as vaginal infection, cervical ulceration, and preterm delivery. Treatment includes conservative and surgical management during pregnancy. A 32-year-old woman presented with a history of vaginal delivery...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Case reports in women's health 2022-07, Vol.35, p.e00421, Article e00421
Hauptverfasser: Vargas, Brandon Alejandro Muñoz, García, Aura Esperanza Velasco, Mendoza, Rafael Leonardo Aragón, Sarmiento, Camilo Alberto Garzón, Vargas, Elman Hackson Leal
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:During pregnancy, pelvic organ prolapse is uncommon and is associated with adverse outcomes such as vaginal infection, cervical ulceration, and preterm delivery. Treatment includes conservative and surgical management during pregnancy. A 32-year-old woman presented with a history of vaginal delivery eight months earlier reported the sensation of a vaginal mass lasting seven months. On physical examination, we noted pelvic organ prolapse and 19-week pregnancy. We treated her conservatively with a Gellhorn pessary and antenatal corticosteroid for fetal lung maturation at 32 weeks due to a high risk of preterm delivery. The pregnancy proceeded with no obstetric complications and vaginal delivery at term of a healthy neonate. Conservative management for patients with pelvic organ prolapse during pregnancy using a pessary is the best option to improve maternal symptomatology and minimize gestational risk; there is no contraindication for vaginal delivery, and cesarean section is reserved for obstetric indications. •During pregnancy, pelvic organ prolapse is uncommon.•Treatment includes conservative and surgical management during pregnancy.•A pessary is the best option to improve maternal symptomatology and minimize gestational risk.
ISSN:2214-9112
2214-9112
DOI:10.1016/j.crwh.2022.e00421